CA-A Cancer Journal for Clinicians

Papers
(The median citation count of CA-A Cancer Journal for Clinicians is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Minority groups underrepresented in hematologic cancer trials18429
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey12939
Breast cancer in a transgender man7575
Cancer treatment and survivorship statistics, 20252229
Near majority of adults favor R ratings for films with smoking2170
Issue Information2056
1652
482
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer353
Colorectal cancer statistics, 2026275
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians215
Correction to “Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline”200
Screening for colorectal cancer177
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types130
Cancer statistics 2024: All hands on deck130
Most patients with cancer are not undergoing germline genetic testing129
Multicancer detection tests: What we know and what we don’t know110
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies109
Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision‐making108
Blood tests for colorectal cancer—Hype ahead of evidence?103
Cancer statistics, 202695
Reviewer acknowledgement 202593
92
Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach85
82
Issue Information79
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial75
Health insurance status and cancer stage at diagnosis and survival in the United States68
More care needed for cancer caregivers68
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review65
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine64
The evolving landscape of tissue‐agnostic therapies in precision oncology54
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future51
Medicaid expansion increases survival for patients with cancer49
Interventional gastroenterology in oncology47
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma46
Study identifies risk factors that may lead to secondary cancers46
Does distance deter male fertility preservation?45
Lung cancer screening guidelines: Smoking matters, not quitting44
Overlooked barriers to implementation of geriatric assessment42
Study assesses normal tissue effects after axillary radiotherapy for early breast cancer41
Prostate cancer statistics, 202537
Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review37
The contemporary management of cancers of the sinonasal tract in adults36
Issue Information32
Colorectal cancer screening: An update to the American Cancer Society guideline, 202632
Cancer survivors at greater risk for bone fractures late in life27
Bilateral mastectomy may not reduce mortality risk25
From medical student to Editor: A note of thanks25
Issue Information23
Twenty‐year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation i22
Issue Information21
Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline20
Breast Cancer Statistics, 202220
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance20
Screening for lung cancer20
Issue Information20
Prevention of device‐related infections in patients with cancer: Current practice and future horizons19
Chemotherapy‐induced taste changes affect nutrition, quality of life19
Cancer treatment and survivorship statistics, 202215
14
Is active surveillance an alternative to surgery for some patients with esophageal cancer?14
Issue Information14
14
Better communication is key for quality‐of‐life improvement in low‐income and minority patients13
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors12
Cancer misinformation on social media11
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries11
Key issues face AI deployment in cancer care10
Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer10
Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma10
10
Social determinants of health and US cancer screening interventions: A systematic review9
Global cancer statistics: A healthy population relies on population health8
Issue Information8
Radiotheranostics in oncology: Making precision medicine possible8
Global cancer statistics for children: Two decades of change and projections to 20508
8
Personalizing therapies over the course of hormone receptor‐positive/HER2‐negative metastatic breast cancer8
Fertility counseling for reproductive‐age women with cancer should address gestational carriers7
Geriatric assessment for the practicing clinician: The why, what, and how7
Cancer statistics, 2025: A hinge moment for optimism to morph into hope?7
Urothelial carcinoma: Perioperative considerations from top to bottom7
Carcinoma of unknown primary: Molecular tumor board‐based therapy6
Smoking cessation support lags behind lung cancer screenings6
6
Is mandated genetic counseling needed?6
Issue Information5
Cancer statistics for A merican I ndian and A l5
Cancer disparities for LGBTQ+ patients identified more fully5
Reviewer acknowledgement 20225
Correction to “Advances in the noninvasive diagnosis of melanoma—40 years beyond the ABCDs”5
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer5
Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer5
The evolving landscape of salivary gland tumors4
New studies examine COVID ‐19 risks among cancer patients4
Sustained weight loss may reduce cancer risk4
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial3
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer3
3
Issue Information3
Issue Information3
Regorafenib as maintenance therapy showed significant delayed progression of non‐adipocytic soft tissue sarcomas3
3
Update and new advances in fertility preservation and cancer3
Study identifies signs and symptoms of colorectal cancer risk at younger ages3
Not only a Western world issue: Cancer incidence in younger individuals in the United Arab Emirates3
3
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management3
Pursuit of precision oncology in the treatment of metastatic hormone receptor–positive breast cancer: Making strides or barely moving?2
Erectile dysfunction common within the first year after rectal cancer surgery2
Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 20252
Erratum to “Cancer statistics, 2024”2
Colon cancer blood test effective for average‐risk population2
Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology2
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians2
A patient with newly diagnosed breast cancer found to have mosaic TP53 likely pathogenic variant2
Cancer statistics for African American and Black people, 20252
2
Issue Information2
Osimertinib prolongs progression‐free lung cancer survival after chemotherapy2
Issue Information2
Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker‐dri1
Cancer statistics, 20251
Correction to “Cancer treatment and survivorship statistics, 2025”1
1
Breast cancer statistics 20241
1
Colonoscopies for patients aged 45–49 years yield positive results1
Examining the interrelationships between mindfulness‐based interventions, depression, inflammation, and cancer survival1
Targeting tumor suppressor gene co‐mutations in EGFR ‐mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification1
Most young female cancer survivors are at minimal risk for obstetric problems1
Correction to “American Cancer Society’s report on the status of cancer disparities in the United States, 2025”1
Cancer in rural America: Improving access to clinical trials and quality of oncologic care1
Cancer statistics, 2026: Charting a course for a national cancer research agenda1
People experiencing homelessness face inpatient care disparities1
The association between menopausal hormone therapy and breast cancer remains unsettled1
Treatment adaptation based on response to induction chemotherapy in nasopharyngeal carcinoma: An evolving landscape1
Immunosurveillance in clinical cancer management1
Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 20221
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 20191
Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack‐year history: A systematic review1
Nonpharmacologic interventions for managing distress, anxiety, and depression for patients with cancer and their family caregivers: A systematic review and meta‐analysis1
Breast cancer survivors face greater cardiometabolic risks1
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature1
Issue Information1
Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer1
1
1
Learning from prostate cancer statistics1
Reviewer acknowledgement 20231
Clinician communication strategies associated with increased uptake of the human papillomavirus ( HPV ) vaccine: A systematic review1
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer1
Cancer care for people with dementia: Literature overview and recommendations for practice and research1
MCED blood test boosts cancer detection in symptomatic patients1
0.047655820846558